SCHEMBL17667993

SCHEMBL17667993

COc1c(F)cc(C(=O)NC(Cc2ccc(-c3ccccc3)cc2)CC(C)C(=O)O)cc1F

nearest known ligand 0.66

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 12/20 0.66
▸ MMEL1 Q495T6 8/20 0.66
▸ ACE P12821 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18672735 0.90 MME (0.54) MMEMMEL1ACE
SCHEMBL2707412 0.90 MME (0.54) MMEMMEL1ACE
SCHEMBL18672691 0.89 MME (0.70) MMEMMEL1ACE
SCHEMBL2705953 0.89 MME (0.70) MMEMMEL1ACE
SCHEMBL18672626 0.84 MME (0.76) MMEMMEL1ACE
SCHEMBL12317265 0.84 MME (0.76) MMEMMEL1ACE
SCHEMBL12317197 0.80 MME (0.81) MMEMMEL1ACE
SCHEMBL18672580 0.80 MME (0.81) MMEMMEL1ACE
SCHEMBL12317248 0.80 MME (0.70) MMEMMEL1ACE
SCHEMBL18672656 0.80 MME (0.70) MMEMMEL1ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3048100-A1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS Novartis AG (CH) 2016-07-27 — — EP disclosed
EP-2435402-B1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS NOVARTIS AG (CH) 2016-04-13 — — EP disclosed
Send feedback